UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 15, 2021
Accession Number:
Submission Type:
CIK:
0001750149
Company Name:
Inhibikase Therapeutics, Inc.
File Number:
333-257032